# Anixa Biosciences Inc: insider transactions

ANIX · Nasdaq · CIK 715446 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/anix.md) · [Financials](/companies/anix/financials.md) · [Filings](/companies/anix/filings.md) · [Insiders](/companies/anix/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Titterton Lewis H jr](/insiders/1499254.md) | Director | Purchase (P) | 8,000 | $2.98 | $23.8k | [Form 4](/filings/0001493152-26-048520.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 16:16 ET. No prices; not investment advice.